Test Price
2,800 AED✅ Home Collection Available
SCARB2 Gene Epilepsy, Progressive Myoclonic Type 4, With or Without Renal Failure Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing with full exon coverage.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM by DHA-licensed phlebotomists.
- ✓Clinical Guidance: Post‑test telephonic interpretation session with a specialist genetic counsellor.
- ✓Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS panel screens the entire coding region of the SCARB2 gene to confirm or rule out Progressive Myoclonus Epilepsy Type 4 (PME4) and evaluate the risk of associated nephropathy. Results guide neurologists and nephrologists in personalizing antiepileptic therapy and renal surveillance.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Method | NGS (full gene sequencing) | Single‑gene Sanger sequencing |
| Turnaround | 3–4 weeks | 6–10 weeks |
| Sensitivity | ≈99.9% for SNVs/indels | ≈95% (limited to known hotspots) |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recommend this test for children and adults with unexplained progressive myoclonus, epilepsy, or renal impairment. A molecular diagnosis of SCARB2-related PME4 empowers families with precise management strategies and informs recurrence risk for future pregnancies. Always interpret genomic results within the full clinical phenotype.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Pre-Test Advisory
Medication Warning
Do not discontinue prescribed antiepileptic or renal medications without consulting your treating physician. Abrupt changes can destabilise seizure control and kidney function.
Safety Exclusion Criteria
- Active febrile illness or systemic infection that may interfere with sample quality.
- Inability to provide informed consent (guardian required for minors).
- Severe coagulopathy contraindicating venipuncture unless a non‑invasive FTA card sample is used.
Emergency Red Flags – Seek Immediate Care
- Prolonged or clustering seizures lasting >5 minutes.
- Rapid decline in kidney function (sudden oliguria, facial swelling, vomiting).
- Severe myoclonus leading to injuries or loss of consciousness.
Patient FAQ & Clinical Guidance
1. How does NGS testing for the SCARB2 gene help my clinical management?
The test identifies disease‑causing mutations in the SCARB2 gene, enabling precise diagnosis of Progressive Myoclonus Epilepsy Type 4 and guiding tailored antiepileptic treatment and renal monitoring from day one.
2. What sample types are accepted and does the collection hurt?
We accept whole blood (3–5 mL EDTA tube), extracted DNA, or a painless finger‑prick dried blood spot on an FTA card. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM.
3. Will my insurance cover this genetic test in the UAE?
Coverage varies by plan; we provide direct insurance verification within 30 minutes via WhatsApp at +971545488731 and can submit pre‑authorisation on your behalf.
4. How long does it take to get results?
Turnaround time is 3 to 4 weeks from sample receipt, with urgent processing available upon request.
5. Is pre-test genetic counselling required?
Yes, a consultation with our genetic counsellor is included in the test package to review family history and prepare you for potential outcomes.
UAE Regulatory & Data Privacy Adherence
All clinical and genetic data are handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | SCARB2 Gene Epilepsy, Progressive Myoclonic Type 4, With or Without Renal Failure Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (3–5 mL EDTA), extracted DNA, or dried blood spot on FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) – full exon coverage and flanking intronic regions |
| ICD-10-CM Code | G40.3 (Generalized idiopathic epilepsy and epileptic syndromes), N18.9 (Chronic kidney disease, unspecified) |
| LOINC Code | 81247-9 (Master panel for Genetic testing) |
| DHA Facility License & Lab Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians